InsidersTradesSigma
경보제약: management transactions · South Korea · DART (FSS)
DART:company-594079KR·DART (FSS)Mcap 143.7Bn€Healthcare
Browse the full management transaction log of 경보제약, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 경보제약 has recorded 1 insider filings. Market capitalisation: €143.7bn. The latest transaction was reported on 19 March 2026 — Purchase. Among the most active insiders: 홍성상. Every trade is free.
1
Insider Decl.
0
Thresholds
€6,454
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
6010.00 €
Analyst consensus
Income statement
Revenue264.10 Bn€
Gross profit102.30 Bn€39% margin
Net income182.3 M€0.1% margin
Valuation
Beta0.37
Balance sheet & cash
Market cap143.68 Bn€
Total debt126.67 Bn€
Free Cash Flow−34.16 Bn€
Debt / Equity87%
Profitability & ownership
ROE0.1%
ROA0.7%
% insiders61.9%
% institutions0.1%
Last declaration on 19 March 2026